An Independent Review
Home About Us Contact Us Index Search Consumer Topics Back Issues

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

LAAM
  • in opioid dependence 24(1) 4-6
    		•
    laboratory results - see abnormal laboratory results
    labour
  • pethidine in labour pain 27(2) 34-5
    		•
    lactation
  • antidepressants 30(5) 125-7
    		•
  • antipsychotics 30(6) 162-3
    		•
  • dental implications 20(2) 51
    		•
  • 'Drugs and breastfeeding' (book review) 27(6) 154
    		•
  • metronidazole (letter) 28(2) 29-33
    		•
  • drugs in human milk 20(2) 35-40
    		•
  • letters 21(4) 87-91; 21(2) 31-4; 21(1) 5-8; 20(4) 83-6
    		•
  • metformin and diabetes 30(3) 68-9
    		•
    lactulose
  • laxatives in aged care (PBAC question) 26(2) 30-2
    		•
    Lamictal
  • see lamotrigine 24(4) 100-2; 17(1) 6-8
    		•
    lamifiban
  • in antiplatelet therapy 19(4) 104-8
    		•
    lamivudine - HIV
  • 3TC (New drug) 19(4) 108-11
    		•
  • abacavir/zidovudine combination - Trizvir (New combination) 24(6) 155-8
    		•
  • Zeffix (New strength) 22(5) 125-7
    		•
    lamotrigine
  • in bipolar disorders 30(3) 70-3
    		•
  • in epilepsy 22(3) 61-3
    		•
  • Lamictal (New drug) 17(1) 6-8
    		•
  • Lamictal (New strength) 24(4) 100-2
    		•
    lanreotide
  • acromegaly - Somatuline LA (New drug) 25(2) 44-7
    		•
    lansoprazole
  • anti-ulcer drug - Zoton (New drug) 17(3) 73
    		•
    lanthanum carbonate hydrate
  • Fosrenol - hyperphosphataemia in chronic renal failure (New drug) 29(2) 53-5
    		•
    Lantus
  • see insulin glargine 27(6) 138-41; 27(2) 50-1
    		•
    lapatinib
  • breast cancer - Tykerb (New drug) 30(5) 133-5
    		•
    laronidase
  • Aldurazyme - mucopolysaccharidosis I (New drug) 30(3) 79-82
    		•
    laser treatment
  • macular degeneration 25(5) 116-9
    		•
    Lasix
  • see frusemide 24(4) 100-2
    		•
    latanoprost
  • in glaucoma 25(6) 142-6
    		•
  • glaucoma - Xalatan (New drug) 21(2) 49-55
    		•
    latex allergy and the use of gloves
  • letter 18(1) 4-7
    		•
    latex in condoms
  • effects of chemicals, drugs 23(6) 129
    		•
    laureth-9
  • varicose veins - Aethoxysklerol (New drug) 25(1) 20-3
    		•
    laxatives
  • in aged care (PBAC question) 26(2) 30-2
    		•
  • bowel preparation 28(1) 16-7
    		•
  • constipation management in children 25(4) 85-7
    		•
  • letter 25(6) 131-2
    		•
    leflunomide
  • in adult rheumatoid arthritis 26(2) 36-40
    		•
  • rheumatoid arthritis - Arava (New drug) 23(1) 21-3
    		•
    left ventricular dysfunction
  • ACE inhibitors in heart failure (editorial) 19(1) 2-3
    		•
  • management of post myocardial infarct patients 19(1) 8-10
    		•
    leg ulcers
  • management 23(1) 6-9
    		•
    legal issues
  • clinical investigations and professional indemnity (editorial) 19(4) 86-7
    		•
  • dental implications 19(4) 97
    		•
  • clinical investigations and professional negligence (editorial) 19(4) 86-7
    		•
  • common law duties of prescribers 19(1) 18-20
    		•
  • Disputes and dilemmas in health law - book review 30(4) 105-6
    		•
  • informed consent 25(5) 114-5
    		•
  • prescribing and the law (editorial) 27(5) 108-9
    		•
  • letters 28(2) 29-33
    		•
  • use of Latin (Letters) 28(2) 29-33
    		•
  • publishing of drug evaluations (editorial) 29(5) 120
    		•
  • letter 30(2) 32-4
    		•
    lenograstim
  • clinical use 17(4) 95
    		•
  • Granocyte (New formulation) 25(4) 94-9
    		•
  • neutropenia - Granocyte (New drug) 17(2) 30-2
    		•
    lepirudin
  • Refludan (New drug) 23(4) 84-7
    		•
    leprosy
  • thalidomide - erythema nodosum leprosum - Thalidomide Pharmion (New drug) 26(6) 146-51
    		•
    lercanidipine
  • hypertension - Zanidip (New drug) 24(6) 155-8
    		•
  • Zanidip (New strength) 27(2) 50-1
    		•
    Lerivon
  • see mianserin 18(1) 7-9
    		•
    Lescol
  • see fluvastatin 19(1) 24-7
    		•
    letrozole
  • breast cancer - Femara (New drug) 21(1) 25-7
    		•
    leukaemia
  • alemtuzumab - MabCampath - chronic lymphocytic leukaemia (New drug) 29(6) 167-71
    		•
  • dasatinib - Sprycel - chronic myeloid and acute lymphoblastic leukaemia (New drug) 30(2) 50-55
    		•
  • rasburicase - hyperuricaemia in chemotherapy - Fasturtec (New drug) 26(3) 68-71
    		•
  • treatment of adult leukaemia 29(3) 76-9
    		•
    leukaemia, chronic lymphocytic
  • fludarabine - Fludara (New drug) 18(4) 86-7
    		•
    leukaemia, chronic myeloid
  • imatinib - Glivec (New drug) 24(5) 129-31
    		•
    leukaemia, hairy cell
  • cladribine - Leustatin (New drug) 18(2) 35-8
    		•
    leukaemia, promyelocytic
  • tretinoin - Vesanoid (New drug) 19(2) 38-40
    		•
    LeukoScan
  • see sulesomab 25(3) 74-5
    		•
    leukotriene inhibitors
  • montelukast - asthma - Singulair (New drug) 21(4) 108-11
    		•
    leukotriene receptor antagonists
  • clinical pharmacology in asthma 22(3) 55-7
    		•
  • montelukast and zafirlukast in asthma 22(3) 58-60
    		•
  • zafirlukast - asthma - Accolate (New drug) 22(2) 43-7
    		•
  • letter 22(6) 131-2
    		•
    leukotrienes
  • metabolism and pharmacology 22(3) 55-7
    		•
    leuprorelin
  • Eligard (New brand) 27(2) 50-1
    		•
  • Lucrin Depot-3-Month (New strength) 21(2) 49-55
    		•
  • in prostate cancer 19(1) 22-4
    		•
    Leustatin
  • see cladribine 18(2) 35-8
    		•
    levamisole
  • colorectal cancer - Ergamisol (New drug) 20(2) 45-51
    		•
    Levemir FlexPen
  • see insulin detemir 28(5) 130-1
    		•
    levetiracetam
  • epilepsy - Keppra (New drug) 24(4) 100-2
    		•
    Levitra
  • see vardenafil 26(3) 68-71
    		•
    levobunolol
  • glaucoma - Betagan (New drug) 17(4) 87-90
    		•
    levobupivacaine
  • anaesthetic - Chirocaine (New drug) 24(5) 129-31
    		•
  • Chirocaine (New strength) 27(5) 131-3
    		•
    levocabastine
  • H1 receptor agonist - Livostin (New drug) 19(3) 81-3
    		•
    levodopa
  • benserazide combination - Madopar (New formulation) 21(2) 49-55
    		•
  • and dopamine cardiovascular pharmacology 17(2) 42-3
    		•
  • and dopamine pharmacology in Parkinson's disease 17(1) 17-21
    		•
  • entacapone adjunct treatment - Parkinson's disease - Comtan (New drug) 22(6) 147-51
    		•
  • in Parkinson's disease 24(4) 92-5
    		•
  • tolcapone adjunct treatment - Parkinson's disease - Tasmar (New drug) 21(2) 49-55
    		•
    levomethodyl acetate
  • in opioid dependence 24(1) 4-6
    		•
    levonorgestrel
  • contraceptive - Mirena (New delivery system) 24(2) 43-7
    		•
  • Postinor-2 (New strength) 25(4) 94-9
    		•
  • progestogen-only contraceptives 22(1) 6-8
    		•
    Lexapro
  • see escitalopram oxalate 27(2) 28-33; 26(6) 146-51
    		•
    LHRH - see luteinising hormone releasing hormone
    Li - see lithium
    lice
  • management 23(3) 62-3
    		•
  • letters 24(1) 3; 23(5) 93-6
    		•
    lichen sclerosus
  • management 24(3) 59-61
    		•
    lifestyle-related disease
  • doctor-patient relations 21(4) 92-4
    		•
    lignocaine
  • prilocaine patch - new formulation - EMLA Patch 17(4) 87-90
    		•
    lindane
  • toxicity and treatment of ectoparasites (letters) 21(1) 5-8; 20(2) 31-2
    		•
    linezolid
  • oxazolidinone antibiotic - Zyvox (New drug) 25(2) 44-7
    		•
    Lioresal Intrathecal
  • see baclofen 19(2) 38-40
    		•
    lipase inhibitors
  • orlistat - Xenical (New drug) 23(3) 64-7
    		•
    Lipidil
  • see fenofibrate 27(4) 101-5
    		•
    lipid-receptor agonists
  • in glaucoma 25(6) 142-6
    		•
    Lipitor
  • see atorvastatin 21(2) 49-55
    		•
    Lipobay
  • see cerivastatin 24(2) 43-7
    		•
    lipoproteins
  • HDL cholesterol - laboratory results 17(4) 99-102
    		•
    lisinopril
  • Lisodur (New brand) 24(2) 43-7
    		•
    Lisodur
  • see lisinopril 24(2) 43-7
    		•
    literature
  • searching 24(5) 116-9
    		•
  • letters 25(4) 79-80; 25(1) 4
    		•
    lithium
  • in bipolar disorders 30(3) 70-3
    		•
  • effects on kidney 23(1) 17-9
    		•
  • Quilonum SR (New formulation) 22(1) 20-3
    		•
  • therapeutic drug monitoring (letter) 20(3) 57-60
    		•
  • and thyroid dysfunction 17(3) 70-2
    		•
    live cholera vaccine
  • Orochol (New drug) 23(4) 84-7
    		•
    liver - see also hepatitis
  • disodium gadoxetate - Primovist - liver imaging (New drug) 29(3) 84-7
    		•
  • liver function tests - hepatitis C 29(2) 36-9
    		•
    liver transplantation
  • tacrolimus - Prograf (New drug) 21(3) 80-3
    		•
  • letter 22(2) 28-31
    		•
    Livial
  • see tibolone 23(4) 84-7
    		•
    Livostin
  • see levocabastine 19(3) 81-3
    		•
    Loceryl
  • see amorolfine 19(1) 24-7
    		•
    lodoxamide
  • see tinzaparin 17(1) 6-8
    		•
    Lomide
  • see lodoxamide 21(2) 49-55
    		•
    long QT syndrome
  • drugs which prolong the QTC interval 25(3) 63-5
    		•
    loperamide
  • Imodium (New formulation) 21(3) 80-3
    		•
  • simethicone - Imodium Advanced (New combination) 23(1) 21-3
    		•
    lopinavir
  • ritonavir combination - HIV - Kaletra (New drug) 24(6) 155-8
    		•
    loratidine
  • pseudoephedrine combination - Clarinase (New formulation) 23(1) 21-3
    		•
  • pseudoephedrine combination - Clarinase Repetabs (New combination) 20(1) 22-3
    		•
    losartan
  • antihypertensive - Cozaar (New drug) 20(2) 45-51
    		•
  • in hypertension 21(4) 95-7
    		•
  • letter 22(3) 53-4
    		•
    Lovan
  • see fluoxetine 23(3) 64-7; 21(4) 108-11
    		•
    Lucentis
  • - see ranibizumab 30(3) 79-82
    		•
    Lucrin Depot-3-Month
  • see leuprorelin 21(2) 49-55
    		•
    lumefantrine/artemether combination
  • malaria - Riamet (New drug) 26(3) 68-71
    		•
    Lumigan
  • see bimatoprost 26(1) 22-3
    		•
    lumiracoxib
  • Prexige - analgesia (New drug) 29(1) 25-7
    		•
  • vascular effects of COX-2 selective inhibitors 27(6) 142-5
    		•
    lung cancer
  • angiogenesis inhibitors 29(1) 13-5
    		•
  • chemotherapy 26(5) 103-5
    		•
  • docetaxel - Taxotere (New drug) 19(2) 38-40
    		•
  • erlotinib - Tarceva - non-small cell lung cancer (New drug) 29(2) 53-5
    		•
  • gefitinib - non-small cell lung cancer - Iressa (New drug) 26(4) 94-5
    		•
  • gemcitabine - Gemzar (New drug) 19(3) 81-3
    		•
  • pemetrexed disodium - Alimta (New drug) 28(1) 19-23
    		•
  • vinorelbine - Navelbine (New drug) 21(2) 49-55
    		•
  • letter 21(4) 87-91
    		•
    lung diseases, chronic
  • air travel 23(5) 107-9
    		•
  • management 30(3) 64-7; 26(2) 33-5; 24(6) 152-5
    		•
  • letter - alpha-1-antitrypsin deficiency 30(6) 140-41
    		•
  • patient support organisations 30(3) 79
    		•
    lung function tests
  • Pocket guide (book review) 29(3) 70
    		•
    lupus
  • patient support organisations 17(3) 61
    		•
    luteinising hormone releasing hormone inhibitors
  • cetrorelix - assisted reproduction - Cetrotide (New drug) 24(6) 155-8
    		•
  • ganirelix - assisted reproduction - Orgalutran (New drug) 24(6) 155-8
    		•
    luteinising hormone, recombinant
  • lutropin alfa - gonadotrophin deficiency - Luveris (New drug) 26(6) 146-51
    		•
    lutropin alfa
  • gonadotrophin deficiency - Luveris (New drug) 26(6) 146-51
    		•
    Luveris
  • see lutropin alfa 26(6) 146-51
    		•
    Luvox
  • see fluvoxamine 20(3) 77-9
    		•
    lymphoma
  • antineoplastic antibodies 26(6) 141-3
    		•
  • rasburicase - hyperuricaemia in chemotherapy - Fasturtec (New drug) 26(3) 68-71
    		•
  • rituximab - Mabthera (New drug) 22(1) 20-3
    		•
    Lyrica
  • see pregabalin 28(3) 75-9
    		•
    lysosome storage diseases
  • alglucerase - Gaucher's disease - Ceredase (New drug) 18(1) 7-9
    		•
  • imiglucerase - Gaucher's disease - Cerezyme (New drug) 22(4) 95-8
    		•
  • laronidase - mucopolysaccharidosis I - Aldurazyme (New drug) 30(3) 79-82
    		•
    Home     Contact Us     Useful Links     Copyright     Privacy     Web Manager